Bioengineered skin substitutes

Methods in Molecular Biology

Volumn 1001, Issue , 2013, Pages 267-278

  Lei, Pedro ^a   You, Hui ^a   Andreadis, Stelios T ^a  

^a State University of New York ^*  (United States)

Author keywords

Differentiation; Epidermal stem cells; Keratinocytes; Three dimensional tissue constructs

Indexed keywords

ATRIAL NATRIURETIC FACTOR; BLOOD CLOTTING FACTOR 8; BLOOD CLOTTING FACTOR 9; COLLAGEN SPONGE; COLLAGEN TYPE 7; CYTOKERATIN 14; CYTOKERATIN 5; DERMATOLOGICAL AGENT; KALININ;

ACELLULAR DERMAL MATRIX; ARTICLE; BASAL CELL CARCINOMA; BIOENGINEERING; BURN; CELL PROLIFERATION; CELL VIABILITY; CHRONIC WOUND; DERMIS; DISEASE SEVERITY; DNA MODIFICATION; ENVIRONMENTAL FACTOR; EPIDERMIS; EPIDERMOLYSIS BULLOSA; EPIDERMOLYSIS BULLOSA DYSTROPHICA; EPITHELIZATION; HEMOPHILIA A; IMMUNOHISTOCHEMISTRY; KERATINOCYTE; LANGERHANS CELL; PLIABILITY; PRIORITY JOURNAL; PROTEIN EXPRESSION; SKIN DISEASE; SKIN STRUCTURE; SKIN SUBSTITUTE; SQUAMOUS CELL CARCINOMA; STEM CELL; STRATUM CORNEUM; SUBCUTANEOUS TISSUE;

ANIMAL TESTING ALTERNATIVES; HISTOLOGICAL TECHNIQUES; HUMANS; IMMUNOHISTOCHEMISTRY; REGENERATIVE MEDICINE; SKIN; SKIN, ARTIFICIAL; SOFT TISSUE INJURIES; STEM CELLS; TISSUE ENGINEERING; TISSUE SCAFFOLDS;

ANIMALIA;

EID: 84877052017     PISSN: 10643745     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-62703-363-3_22     Document Type: Article

References (45)

1. Medalie DA, Eming SA, Collins ME et al (1997) Differences in dermal analogs in fl uence subsequent pigmentation, epidermal differentiation, basement membrane, and rete ridge formation of transplanted composite skin grafts. Transplantation 64:454-465
2. Hilal L, Rochat A, Duquesnoy P et al (1993) A homozygous insertion-deletion in the type VII collagen gene (COL7A1) in Hallopeau- Siemens dystrophic epidermolysis bullosa. Nat Genet 5:287-293
3. Jarvikallio A, Pulkkinen L, Uitto J (1997) Molecular basis of dystrophic epidermolysis bullosa: mutations in the type VII collagen gene (COL7A1). Hum Mutat 10:338-347
4. Chamcheu JC, Siddiqui IA, Syed DN et al (2011) Keratin gene mutations in disorders of human skin and its appendages. Arch Biochem Biophys 508:123-137
5. Khavari PA, Rollman O, Vahlquist A (2002) Cutaneous gene transfer for skin and systemic diseases. J Intern Med 252:1-10
6. Woodman SE, Lazar AJ, Aldape KD et al (2012) New strategies in melanoma: molecular testing in advanced disease. Clin Cancer Res 18(5):1195-1200
7. Meana A, Iglesias J, Del Rio M et al (1998) Large surface of cultured human epithelium obtained on a dermal matrix based on live fi broblast-containing fi brin gels. Burns 24: 621-630
8. Mansbridge J (2002) Tissue-engineered skin substitutes. Expert Opin Biol Ther 2:25-34
9. Liu K, Yang Y, Mansbridge J (2000) Comparison of the stress response to cryopreservation in monolayer and three-dimensional human fi broblast cultures: stress proteins, MAP kinases, and growth factor gene expression. Tissue Eng 6:539-554
10. Pinney E, Liu K, Sheeman B et al (2000) Human three-dimensional fi broblast cultures express angiogenic activity. J Cell Physiol 183:74-82
11. Healy CM, Boorman JG (1989) Comparison of E-Z Derm and Jelonet dressings for partial skin thickness burns. Burns Incl Therm Inj 15:52-54
12. Vanstraelen P (1992) Comparison of calcium sodium alginate (KALTOSTAT) and porcine xenograft (E-Z DERM) in the healing of splitthickness skin graft donor sites. Burns 18:145-148
13. Falanga V, Sabolinski M (1999) A bilayered living skin construct (APLIGRAF) accelerates complete closure of hard-to-heal venous ulcers. Wound Repair Regen 7:201-207
14. Windsor ML, Eisenberg M, Gordon-Thomson C et al (2009) A novel model of wound healing in the SCID mouse using a cultured human skin substitute. Australas J Dermatol 50:29-35
15. Burke JF, Yannas IV, Quinby WC Jr et al (1981) Successful use of a physiologically acceptable arti fi cial skin in the treatment of extensive burn injury. Ann Surg 194:413-428
16. Yannas IV, Burke JF (1980) Design of an arti fi cial skin. I. Basic design principles. J Biomed Mater Res 14:65-81
17. Yannas IV, Burke JF, Gordon PL et al (1980) Design of an arti fi cial skin. II. Control of chemical composition. J Biomed Mater Res 14:107-132
18. Mostow EN, Haraway GD, Dalsing M et al (2005) Effectiveness of an extracellular matrix graft (OASIS Wound Matrix) in the treatment of chronic leg ulcers: a randomized clinical trial. J Vasc Surg 41:837-843
19. Livesey SA, Herndon DN, Hollyoak MA et al (1995) Transplanted acellular allograft dermal matrix. Potential as a template for the reconstruction of viable dermis. Transplantation 60:1-9
20. Cuono C, Langdon R, McGuire J (1986) Use of cultured epidermal autografts and dermal allografts as skin replacement after burn injury. Lancet 1:1123-1124
21. Ramos-e-Silva M, Ribeiro de Castro MC (2002) New dressings, including tissueengineered living skin. Clin Dermatol 20: 715-723
22. Andreadis ST (2004) Gene transfer to epidermal stem cells: implications for tissue engineering. Expert Opin Biol Ther 4:783-800
23. Andreadis ST, Hamoen KE, Yarmush ML et al (2001) Keratinocyte growth factor induces hyperproliferation and delays differentiation in a skin equivalent model system. FASEB J 15:898-906
24. Fentem JH, Botham PA (2002) ECVAM's activities in validating alternative tests for skin corrosion and irritation. Altern Lab Anim 30(Suppl 2):61-67
25. Tornier C, Rosdy M, Maibach HI (2006) In vitro skin irritation testing on reconstituted human epidermis: reproducibility for 50 chemicals tested with two protocols. Toxicol In Vitro 20:401-416
26. Hagino S, Okazaki Y, Itagaki H (2008) An in vitro tier evaluation for the identi fi cation of cosmetic ingredients which are not ocular irritants. Altern Lab Anim 36:641-652
27. Roguet R, Cohen C, Dossou KG et al (1994) Episkin, a reconstituted human epidermis for assessing in vitro the irritancy of topically applied compounds. Toxicol In Vitro 8:283-291
28. Cotovio J, Onno L, Justine P et al (2001) Generation of oxidative stress in human cutaneous models following in vitro ozone exposure. Toxicol In Vitro 15:357-362
29. Kim KH, Chung CB, Kim YH et al (2005) Cosmeceutical properties of levan produced by Zymomonas mobilis. J Cosmet Sci 56:395-406
30. Lelievre D, Justine P, Christiaens F et al (2007) The EpiSkin phototoxicity assay (EPA): development of an in vitro tiered strategy using 17 reference chemicals to predict phototoxic potency. Toxicol In Vitro 21:977-995
31. Chen M, Kasahara N, Keene DR et al (2002) Restoration of type VII collagen expression and function in dystrophic epidermolysis bullosa. Nat Genet 32:670-675
32. Choate KA, Medalie DA, Morgan JR et al (1996) Corrective gene transfer in the human skin disorder lamellar ichthyosis. Nat Med 2:1263-1267
33. Freiberg RA, Choate KA, Deng H et al (1997) A model of corrective gene transfer in X-linked ichthyosis. Hum Mol Genet 6:927-933
34. Fakharzadeh SS, Zhang Y, Sarkar R et al (2000) Correction of the coagulation defect in hemophilia A mice through factor VIII expression in skin. Blood 95:2799-2805
35. Gerrard AJ, Hudson DL, Brownlee GG et al (1993) Towards gene therapy for haemophilia B using primary human keratinocytes. Nat Genet 3:180-183
36. Larcher F, Del Rio M, Serrano F et al (2001) A cutaneous gene therapy approach to human leptin de fi ciencies: correction of the murine ob/ob phenotype using leptin-targeted keratinocyte grafts. FASEB J 15:1529-1538
37. Lei P, Ogunade A, Kirkwood KL et al (2007) Ef fi cient production of bioactive insulin from human epidermal keratinocytes and tissue-engineered skin substitutes: implications for treatment of diabetes. Tissue Eng 13:2119-2131
38. Tian J, Lei P, Laychock SG et al (2008) Regulated insulin delivery from human epidermal cells reverses hyperglycemia. Mol Ther 16:1146-1153
39. Therrien JP, Kim SM, Terunuma A et al (2010) A gene therapy approach for long-term normalization of blood pressure in hypertensive mice by ANP-secreting human skin grafts. Proc Natl Acad Sci USA 107:1178-1183
40. Andreadis ST (2006) Experimental models and high-throughput diagnostics for tissue regeneration. Expert Opin Biol Ther 6:1071-1086
41. Andreadis ST (2007) Gene-modi fi ed tissueengineered skin: the next generation of skin substitutes. Adv Biochem Eng Biotechnol 103:241-274
42. Geer DJ, Swartz DD, Andreadis ST (2004) In vivo model of wound healing based on trans planted tissue-engineered skin. Tissue Eng 10:1006-1017
43. Geer DJ, Swartz DD, Andreadis ST (2005) Biomimetic delivery of keratinocyte growth factor upon cellular demand for accelerated wound healing in vitro and in vivo. Am J Pathol 167:1575-1586
44. Medalie DA, Eming SA, Tompkins RG et al (1996) Evaluation of human skin reconstituted from composite grafts of cultured keratinocytes and human acellular dermis transplanted to athymic mice. J Invest Dermatol 107: 121-127
45. Lugo LM, Lei P, Andreadis ST (2011) Vascularization of the dermal support enhances wound re-epithelialization by in situ delivery of epidermal keratinocytes. Tissue Eng Part A 17:665-675